Skip to content

Supplier News

Coca-Cola introduces Caffeine Free Coke Zero

Coca-Cola Co. has added a no-caffeine product to its Coke Zero soft drink line. The beverage giant said Wednesday that the new Caffeine Free Coke Zero, which has no calories, gives consumers "a great-tasting option for later-in-the-day consumption.

Lay’s Wavy gets new flavor, new look

Frito-Lay North America has extended its Lay’s Wavy potato chip line with the introduction of Lay’s Wavy Garlic & Sea Salt. The PepsiCo snack subsidiary said the new Lay’s Wavy Roasted Garlic & Sea Salt potato chips will be available in stores nationwide this month in a 9.5-ounce bag for a suggested

Taro cleared to market Topicort spray

Taro Pharmaceutical Industries Ltd. has received approval from the Food and Drug Administration for Topicort Topical Spray 0.25%. The company said Friday that the Topicort (desoximetasone) spray, a corticosteroid, is indicated for the treatment of plaque psoriasis in patients age 18 and older.

Warner Chilcott receives FDA approval for Doryx tablets

Warner Chilcott has been cleared by the Food and Drug Administration to market 200-mg strength of Doryx delayed-release tablets. The Ireland-based pharmaceutical company said Friday that it expects the commercial launch of the Doryx tablets to take place in July.

MyAllergyTest at-home kit rolls out to pharmacies

ImmuneTech Inc. has introduced MyAllergyTest, which the company calls the first Food and Drug Administration-cleared, at-home test that allows allergy sufferers to test themselves for 10 key allergens, ranging from food and environmental to inhalants and animal.

Culturelle releases adult chewable probiotic

Culturelle has launched an adult-strength chewable version of its probiotic supplement. The company said Monday that Culturelle Digestive Health Probiotic Chewables enable easier daily probiotic consumption for the many adults who have difficulty swallowing pills.

Mylan ships generic version of Zovirax

Mylan Inc. has released acyclovir ointment 5%, an antiviral medication for the treatment of herpes. The company said Wednesday that its product is is the first generic version of Valeant Pharmaceuticals’ Zovirax Ointment.